Le Lézard
Classified in: Health
Subjects: PSF, CFG, MAT

Health Canada Statement on Use of Vaping Products by Youth


OTTAWA, Nov. 15, 2018 /CNW/ - The U.S. Food and Drug Administration (FDA) has reported a significant increase in the use of vaping products by youth in the United States. As a result, the FDA has announced new measures to restrict youth access to vaping products and new restrictions on flavoured tobacco products.

While Canada has not seen a similar spike in the use of vaping products by youth, Health Canada is concerned and has been taking action. The most recent Canadian Tobacco, Alcohol and Drugs Survey (CTADS), which was released at the end of October, shows that the use of vaping products by youth in Canada is steady and well below levels being reported in the United States. But this is a rapidly evolving market with new products regularly being introduced into Canada, and so Health Canada is watching carefully. 

Canada has already established a strong regulatory framework for vaping products, with a focus on preventing uptake by youth and non-smokers. On May 23, 2018, Canada passed into law the new Tobacco and Vaping Products Act (TVPA). The Act creates a national minimum age of access for vaping products of 18 years. It also includes significant restrictions on the promotion of vaping products, such as bans on:

Additional restrictions under the TVPA are set to come into force on November 19, 2018. These include bans on:

The FDA has also announced its intention to prohibit the use of menthol in tobacco products, and a ban on flavoured cigars. Canada has already banned the use of additives, including flavours, in cigarettes, blunt wraps and most cigars, and a total prohibition against the use of menthol in tobacco products comes into force on November 19, 2018.

Health Canada continues to carefully monitor the Canadian market for signs of an increase in the use of vaping products by youth.

Associated Links
2017 Canadian Tobacco, Alcohol and Drugs Survey 
2016-17 Canadian Student Tobacco, Alcohol and Drugs Survey 
Health Canada Vaping Information 
Tobacco and Vaping Products Act 
Contact Health Canada to report a vaping product promotion that targets youth

 

SOURCE Health Canada


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...

at 08:00
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...



News published on and distributed by: